Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

Clinical trial NCT06964087 · RECRUITING

Trial details

NCT number: NCT06964087
Sponsor: Op-T LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type I Diabetes

Start date: 2026-04-10
Primary completion: 2026-05-31
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.